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Low incidence of IgA nephropathy in blacks. The clinical and
pathologic features were evaluated in 106 IgA nephropathy patients
identified in 1,753 consecutive patients undergoing renal biopsy in the
southeastern United States. Special attention was paid to the propor-
tion of Blacks among the IgA nephropathy patients compared with
non-IgA nephropathy patients, and any differences in clinical or
pathologic findings between Whites and Blacks with IgA nephropathy.
The incidence oflgA nephropathy was approximately six times lower in
Blacks (6 out of 461) than in Whites (100 out of 1,292) undergoing renal
biopsy (P < 0.001). There were no morphologic or im-
munohistopathologic differences between Whites and Blacks with IgA
nephropathy. The only clinical difference was a marked shift in the male
to female sex ratio from 3.5:1 in Whites to 1:5 in Blacks (P < 0.004).
The low incidence and reversed sex ratio of IgA nephropathy in Blacks
were also supported by a review of previously published data.
Faible incidence de la néphropathie a dépôts d'IgA chez les noirs. Nous
avons dvalud les caractdristiques cliniques et pathologiques de 106
patients atteints de ndphropathie a ddpôts d'IgA identifids parmi 1753
patients consdcutifs ayant eu une biopsie rénale dans la region sud-est
des Etats Unis. Une attention particulière a été accordée ala proportion
de sujets noirs parmi les patients atteints de ndphropathie a ddpôts
d'IgA, compares avec des patients atteints d'autres ndphropathies,
ainsi qu'à toute difference dans les caractères cliniques ou
pathologiques entre les sujets noirs ou blancs atteints de ndphropathie
a depOts d'IgA. L'incidence de La ndphropathie a ddpôts d'IgA a dtd
approximativement 6 fois moindre chez les noirs (6 patients sur 461) que
chez les blancs (100 patients sur 1292) parmi les sujets ayant une biopsie
rdnale (p < 0.001). Aucune difference morphologique ou im-
munohistopathologique n'a été trouvë entre les noirs et les blancs
atteints de néphropathie a dépâts d'IgA. La seule difference a été une
modification nette du sex-ratio (H:F), de 3,5:1 chez les blancs a 1:5 chez
les noirs (p < 0.004). La faible incidence de la ndphropathie a ddpôts
d'IgA et l'inversion du sex-ratio chez les noirs atteints de Ia maladie a
ete confirmée par une revue des données précédemment publiées.
Since its description in 1968 by Berger and Hinglais [1], the
clinical and pathologic features of IgA nephropathy have been
studied extensively. Virtually every clinicopathologic discus-
sion of IgA nephropathy notes the predilection of this disease
for males, the frequency of hematuria in affected individuals,
and the characteristic mesangial hypercellularity seen by light
microscopy.
However, most studies have also demonstrated substantial
clinical and pathologic heterogeneity. The initial clinical manifes-
tations of IgA nephropathy may be asymptomatic gross or micro-
scopic hematuria, acute nephritis, rapidly progressive nephritis,
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acute renal failure, or nephrotic syndrome. The underlying
glomerular lesions can range from mild mesangial expansion to
severe glomerular inflammation, even with extensive crescent
formation. The nature and degree ofglomerular, tubulointerstitial,
and vascular injury correlate with the severity ofrenal dysfunction
at the time of biopsy and with the prognosis.
Only a few reports point out the marked racial predilection of
IgA nephropathy for Whites compared with Blacks [2—6]. The
data presented here further document this predilection in the
United States. The clinical and pathologic data are collected
from the largest group of IgA nephropathy patients yet reported
in North America. Probably due to the criteria used to select
patients for renal biopsy, the overall severity of the clinical and
pathologic features of our IgA nephropathy patients is greater
than in any previously reported series.
Methods
The clinical and pathologic data from the last 106 consecutive
patients whose renal biopsy specimens were diagnostic for IgA
nephropathy were compiled. All specimens were evaluated in
the Nephropathology Laboratory of the Department of Pathol-
ogy, the University of North Carolina at Chapel Hill. Over 90%
of the renal biopsy specimens evaluated in this laboratory are
from patients residing in North Carolina, with these specimens
being referred from hospitals throughout the state. The remain-
ing specimens are sent primarily from Virginia, South Carolina,
and Georgia. Over the interval when the 106 IgA nephropathy
specimens were received, a total of 1 ,753 renal biopsy speci-
mens were evaluated.
All 106 IgA nephropathy specimens were evaluated by direct
immunofluorescence using standard procedures [7], and anti-
bodies specific for IgG, 1gM, IgA, C3, C4, Clq, and
fibrin/fibrinogen. The composition, intensity (0 to 4+), and
location (for example, mesangial or capillary wall) of glomerular
immunostaining was determined by one of the authors (JCJ). A
diagnosis of IgA nephropathy was made when IgA was found to
be the most intensely staining glomerular immunoglobulin (Fig.
1). No IgA nephropathy patients had serologic or clinical data
indicative of systemic lupus erythematosus, and none had
evidence for liver disease. Six patients had clinical evidence for
Henoch-SchOnlein purpura.
Transmission electron microscopy was carried out on 102 of
the specimens using standard techniques [7] and included an
evaluation of the presence and location of glomerular electron
dense deposits. Adequate tissue (specifically, cortical tissue
with 10 or more glomeruli) was available from 99 specimens for
light microscopic categorization of glomerular lesions into: (1)
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Fig. 1. Intense IgA immunostaining in the glomerular mesangium of a
patient with IgA nephropathy. (x400)
no light microscopic abnormality; (2) focal mesangioprolifera-
tive glomerulopathy characterized by exclusively mesangial
hypercellularity (Fig. 2) in less than 75% of glomeruli; (3) diffuse
mesangioproliferative glomerulopathy characterized by exclu-
sively mesangial hypercellularity in greater than 75% of
glomeruli; (4) focal proliferative glomerulonephritis character-
ized by less than 75% of glomeruli having, in addition to
mesangial hypercellularity, any more destructive lesions, such
as necrosis, sclerosis, obliteration of capillary lumens, adhe-
sions to Bowman's capsule, or crescent formation (Fig. 3); (5)
diffuse proliferative glomerulonephritis characterized by
greater than 75% of glomeruli having the lesions described for
the previous category; or (6) crescentic glomerulonephritis
characterized by 80% or more of glomeruli having crescent
formation. The degree of tubulointerstitial injury was subjec-
tively quantified from 0 to 4+; with 1 + indicating injury to less
than 25% of the tubulointerstitial compartment, 2+ indicating
injury to 25 to 50%, 3 + indicating 51 to 75%, and 4+ indicating
greater than 75%.
For the purposes of this study, compilation of clinical data
was confined to the time of biopsy. Age, sex, race, and the
presence or absence of hematuria (greater than 5 red blood cell
per high power field), proteinuria, and renal insufficiency (se-
rum creatinine greater than 1.5 mgldl) were determined for all
Fig. 2. Glomerular mesangial hypercellularity and matrix expansion in
a patient with IgA nephropathy. (periodic acid Schiff stain, X 370)
106 patients. The following data were available for a portion of
the patients: blood pressure (79 patients), 24-hr urine protein
excretion (76 patients), creatinine clearance (51 patients), se-
rum C3 level (61 patients), serum antinuclear antibody level (63
patients), and serum ASO titer (34 patients).
For statistical analysis of the difference in incidence of IgA
nephropathy between Whites and Blacks, a large-sample test
procedure for the null hypothesis (proportion 1 = proportion 2)
was performed. The significance of the different sex ratios
between Whites and Blacks was analyzed by a Fisher's exact
test. These analyses were carried out by the Department of
Biostatistics, University of North Carolina School of Public
Health.
Results
Pathologic data
As shown in Table 1, and as would be dictated by definition,
IgA was present in 100% of IgA nephropathy specimens, and
had a mean intensity of 3.3+. IgA immunostaining was always
either exclusively or predominantly within the mesangium, and,
when present in capillaries, was always focal and segmental. C3
immunostaining was seen in all but one specimen, and had a
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an average of 7.7% of glomeruli; while ten of 48 DPO specimens
had crescents, involving an average of 3 1.0% of glomeruli.
In specimens categorized as DPG, the more destructive
lesions were usually focal, and superimposed on diffuse mesan-
gial hypercellularity and matrix expansion. The severity of
tubulointerstitial injury corresponded to the severity of glomer-
ular injury (Fig. 4), with FMG and DMG having 0.5+ mean
tubulointerstitial injury, FPG 1.3+, DPG 2.1+, and CO 3.3+.
Hyperplasia of mural smooth muscle and sclerotic arterial and
arteriolar lesions showed a similar correlation with the degree
of glomerular injury.
By electron microscopy, mesangial electron dense deposits
were found in 97% of specimens, subendothelial dense deposits in
24%, and subepithelial dense deposits in 20%. Subendothelial and
subepithelial dense deposits were observed most frequently in IgA
nephropathy specimens having crescentic glomerulonephritis.
Clinical data
Fig. 3. Severely injured glomerulus with hypercellularity and crescent
formation in a patient with IgA nephropathy. (H & E stain, x380)
mean intensity of 2.6+. In spite of this relatively conspicuous
C3, there was only low-frequency, low-intensity immunostain-
ing for C4 and Clq. In most, but not all, specimens there was
low-intensity 1gM and IgG. In two cases, the IgG showed more
extensive capillary wall localization, in a subepithelial distribu-
tion, than did the IgA; but the mesangial IgA was more intense
overall in the glomeruli.
When the IgA nephropathy specimens were categorized as to
light microscopic glomerular lesions, there was no difference
among the categories with respect to immunoglobulin or com-
plement composition or intensity. Specifically, there was no
greater degree of IgG, 1gM, or C3 immunostaining in the more
destructive categories of injury. Approximately 20% of speci-
mens had well-defined mesangial immunostaining for fibrinlfibrin-
ogen, including seven specimens with 2+ to 3 + staining.
By light microscopy, of the 99 specimens that could be
categorized based on glomerular lesions, one had no discernible
lesions, ten focal mesangioproliferative glomerulopathy (FMG),
ten diffuse mesangioproliferative glomerulopathy (DMG), 20
focal proliferative glomerulonephritis (FPG), 48 diffuse prolif-
erative glomerulonephritis (DPG), and ten crescentic glomeru-
lonephritis (CG) (that is, with 80% or more of glomeruli having
crescents). Three of 20 FPG specimens had crescents, involving
Clinical data are detailed in Table 2. The IgA nephropathy
patients had a mean age of 32 years. There was a predilection
for males versus females (2.9:1) and for Whites versus Blacks
(16.7:1). These predilections remained true for all the categories
of glomerular injury.
Except for a minority of the patients with FMG, all patients
had hematuria. As shown in Table 2 and Figure 4, the degree of
proteinuria, renal insufficiency, and hypertension correlated
with the severity of glomerular injury, with progressively
greater dysfunction in the following order: FMG, DMG, FPG,
DPG, CG.
The serum C3 was low in only one of 61 patients. One of 63
patients had a positive antinuclear antibody determination.
Four of 34 patients had an ASO titer of greater than 200 Todd
units.
Of the 106 IgA nephropathy patients, 100 were White and
only six Black, for a ratio of 16.7:1. According to the 1980
United States Census, the ratio of Whites to Blacks in North
Carolina is 3.5:1. The overall ratio of Whites to Blacks in
patients whose renal biopsy specimens were evaluated in our
laboratory during the study was 2.8:1. Of 1,292 Whites, 100 had
IgA nephropathy; while only six of 461 Blacks had IgA
nephropathy. This was a statistically significant difference (P <
0.001). Therefore, there was an approximately sixfold decrease
in the proportion of Blacks with IgA nephropathy compared
with other renal diseases leading to renal biopsy. Evaluation of
100 of the idiopathic (nonlupus) membranous glomerulopathy
patients diagnosed over the same time interval showed a White
to Black ratio of 2.2:1.
Of the six Blacks with IgA nephropathy, two had FMG, three
FPG, and one CO. They had the same distribution and compo-
sition of immunostaining as Whites. As shown in Table 3, the
clinical findings in Blacks were similar to that in Whites, with
slightly less severe average dysfunction. The most striking
difference was a shift in the male:female ratio from 3.5:1 for
Whites to 1:5 for Blacks. Even with the small number of Blacks
available for comparison, this difference was statistically signif-
icant when analyzed by Fisher's exact test (P < 0.004).
Table 3 also details the comparative clinical data between
males and females, and between younger (less than 30 years
old) and older (30 or more years old) patients with IgA nephrop-
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Table 1. Pathologic data for IgA nephropathy specimens
All patients
Light microscopic lesion
FMG DMG FPG DPG CG
Number of patients 106 10 10 20 48 10
IgA deposits 100/3,30 100/3.1 100/3.3 100/3.5 100/3.4 100/3.3
IgG deposits 65/1.3 40/1.3 70/1.4 85/1.3 69/1.3 40/1.0
1gM deposits 80/1.1 90/1.1 90/1.0 70/1.1 81/1.1 80/1.2
C3 deposits 99/2.6 100/2.4 100/2.7 100/2.6 98/2.6 100/2.9
C4deposits 22/1.0 20/1.0 10/1.0 15/1.0 28/1.1 22/1.0
Clq deposits 12/1.0 12/1.0 0/- 6/1.0 12/1.0 14/1.0
% with mesangial dense deposits 97 100 100 100 96 100
% with subendothelial dense deposits 24 20 20 10 27 50
% with subepithelial dense deposits 20 0 30 5 22 40
% with crescents 23 0 0 15 21 100
Tubulointerstial injury (1—4+) 1.7 0.5 0.5 1.3 2.1 3.3
Abbreviations are: FMG, focal mesangial glomerulopathy; DM0, diffuse mesangial glomerulopathy; FPG, focal proliferative glomerulonephri-
tis; DPG, diffuse proliferative glomerulonephritis; CG, crescentic glomerulonephritis.
Percentage of specimens with deposits/mean intensity (1—4+) when present.
FMG DMG FPG DPG CG
Fig. 4. Correlation of IgA nephropathy glomerular lesion (F, focal; D,
dUfuse: MG, mesangioproliferative glomerulopathy; PG, proliferative
glomerulonephritis, CG, crescentic glomerulonephritis) with serum
creatinine, proteinuria, blood pressure, and degree of tubulointerstitial
injury.
athy. Females had a lower White:Black ratio than males, but
age had no effect on the Black:White ratio.
Discussion
IgA nephropathy is defined by its distinctive im-
munohistopathologic features, and is now known to have a
broad spectrum of clinical presentations, related to the severity
of the underlying renal parenchymal injury. The ubiquitous
finding of hematuria and the male predominance are widely
recognized clinical characteristics of IgA nephropathy. Al-
though there has been much discussion about the varying
incidence of IgA nephropathy among different populations and
the importance of genetics in susceptibility for this disease,
there has been little attention paid the markedly lower incidence
of this disease in Blacks.
Table 4 is a compilation of published data that detail the
clinicopathologic features of IgA nephropathy in the United
States. In addition to our data, there are six reports that give the
racial distribution of IgA nephropathy [2—6, 15]. Of the 321
patients with IgA nephropathy, 11 were Black. Only 3.4% of
IgA nephropathy patients in the United States are Black, while
11.8% of the total population is Black [16]. In our biopsied
patients, one out of 13 Whites (100/1,292) had IgA nephropathy,
compared to one out of 77 Blacks (6/461) (P < 0.001). Thus, the
incidence of IgA nephropathy in biopsied patients is approxi-
+ mately six times greater in Whites than Blacks. Evidence that
the difference between Whites and Blacks is not due to failure
3 to biopsy Blacks is our observation that the proportion of
Blacks to Whites in our renal biopsy population (1:2.8) is
2 actually greater than in the referral population (1:3.5). Also, in
a another specific glomerular disease category, namely, patients
1
with idiopathic membranous glomerulopathy, the proportion of
Blacks (1:2.2) is comparable to that in the total biopsy popula-
tion. In another clinicopathologic study of patients in our renal
biopsy population [17], we observed a Black to White ratio of
1:2.3 in 223 patients with nonlupus proliferative glomerulone-
phritis, 3.8:1 in 30 proliferative lupus glomerulonephritis pa-
tients, and 1.5:1 in a newly described form of glomerulonephri-
tis called Clq nephropathy. The first group shows that the
majority of our proliferative glomerulonephritis patients have a
racial distribution similar to the total biopsy population, and the
latter two groups show that some specific types of proliferative
glomerulonephritis have markedly increased proportions of
Blacks.
There is variability in the proportion of Blacks in the IgA
nephropathy populations reported from different states. This is
most likely due to the proportion of Blacks in the population
from which the patients came; in other words, IgA nephropathy
patients from urban areas or states with high proportions of
Blacks would be expected to be more often Black. For instance,
there were six Blacks out of 126 IgA nephropathy patients from
North Carolina, which has 22.4% Blacks; while there were no
Blacks out of 82 patients from Kentucky (7.1% Blacks in the
population) or out of 62 patients from New Mexico (1.8%
Blacks) [16].
The incidence of IgA nephropathy varies among different
populations throughout the world, accounting for less than 10%
of all biopsied patients in North America, approximately 20% of
all patients with primary glomerulonephritis in Europe and
Australia, and more than 30% of primary glomerulonephritis
patients in Japan [18]. There is little difference between North
America and Europe when the incidence of IgA nephropathy is
calculated by a standard approach, for example, based either on
the percentage of all biopsied patients, or on the percentage of
patients with primary glomerulonephritis. Since the United
States has a higher proportion of Blacks, who have a low
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Table 2. Clinical data at the time of biopsy in IgA nephropathy patients
Light microscopic lesion
All patients FMG DMG FPG DPG CO
Mean age 31.7 28.2 21.5 33.0 34.7 27.0
Sex, male.female 79:27 6:4 7:3 12:8 40:8 8:2
Race, White:Black 100:6 8:2 10:0 17:3 48:0 9:1
% with hematuria 96 80 100 100 100 100
% with proteinuria 91 50 70 100 100 100
Grams protein/24-hr 3.5 1.6 2.0 4.3 3.7 5.7
% with creatinine> 1.5 mg/dl 49 30 30 37 54 90
Mean creatinine 2.2 1.4 1,5 1.8 2.1 4.1
Mean creatinine clearance 78 90 72 85 83 27
Mean blood pressure (BP) 141/89 129/77 119/76 137/85 141/90 168/106
% with diastolic BP > 90 27 0 0 25 25 57
Abbreviations same as Table 1.
Table 3. Comparison of IgA nephropathy between Whites and Blacks, males and females, and young and old
Younger Older
White Black Male Female <30 years  30 years
Number of patients 100 6 79 27 53 53
Mean age 31.6 32.5 32.6 29.1 18.9 44.5
Sex, male:female 78:22 1:5 — — 29:14 40:13
Race, White:Black — — 78:1 22:5 50:3 50:3
% with hematuria 97 83 96 96 98 94
% with proteinuria 91 83 95 78 89 92
Grams proteinl24-hr 3.5 4.2 3.4 3.9 3.2 3.9
% with creatinine > 1.5 mg/dl 51 17 53 37 40 58
Mean creatinine 2.2 1.3 2.3 1.8 2.2 2.2
Mean creatinine clearance 78 82 78 81 82 74
Mean blood pressure (BP) 141/89 134/86 143/90 135/85 136/88 143/90
% with diastolic BP > 90 27 20 25 30 24 29
incidence of IgA nephropathy, the incidence of IgA nephrop-
athy in the United States might be expected to be slightly lower
than that in Europe. In addition to genetic factors, environmen-
tal factors and criteria for performing renal biopsies could
influence the incidence of IgA nephropathy observed in a given
population.
Some racial groups appear to have a higher incidence of IgA
nephropathy than do Whites, such as the Japanese [18] and
American Indians [15]. The similarly high incidence in these
geographically distant populations could be due to the common
Mongoloid lineage of both Japanese and American Indians.
Important data supporting the low incidence of IgA nephrop-
athy in Blacks would be renal biopsy findings obtained from a
predominantly Black population. Unfortunately, we were un-
able to locate such data. Two recent reviews of renal disease in
Africa note the high frequency of nephritis and nephrotic
syndrome, often associated with infectious disease, but do not
mention IgA nephropathy [19, 20]. Two cases of IgA nephrop-
athy reported from Johannesburg, South Africa, were both in
White patients [21].
IgA nephropathy is morphologically and immunohistopatho-
logically indistinguishable in Whites and Blacks. The only
striking clinical difference between Whites and Blacks with IgA
nephropathy is a marked shift in the male:female ratio from
3.5:1 in Whites to 1:5 in Blacks (P < 0.004) (Table 3). The male
predominance in the White pateints is similar to that reported in
other studies of IgA nephropathy from North America, Europe,
and Asia [18]. In addition to our six patients, we found four
other Black IgA nephropathy patients whose sex was reported
in the literature [4, 5] and all were females, bringing the total to
nine females and one male out of ten Black IgA nephropathy
patients. This change, in Blacks, of the sex ratio is also
indicated by the lower proportion of Blacks to Whites among
males with IgA nephropathy (1:78) compared to females (5:22).
Young and old patients had the same White to Black ratio.
The pathologic findings in our 106 IgA nephropathy patients
resemble those reported previously [1—15], except for a higher
proportion of more severe lesions, including crescentic glomer-
ulonephritis. Similarly, the clinical findings are similar to pre-
viously reported data [1—15], but with a greater proportion of
patients having renal insufficiency and proteinuria (Table 4).
These somewhat more severe clinical and pathologic features in
our IgA nephropathy patients are most likely due to the criteria
used to select patients for biopsy. Most nephrologists referring
specimens to our renal biopsy service do not biopsy patients
with hematuria but normal renal function and no or low level
proteinuria. Therefore, most of our biopsied IgA nephropathy
patients have, in addition to hematuria, substantial proteinuria
and/or renal insufficiency.
In conclusion, IgA nephropathy has a much lower incidence
in Blacks than Whites. When it occurs in Blacks, females are
much more often affected, which is a reversal of the sex ratio in
Whites. There is no difference in the pathologic lesions or renal
dysfunction induced by IgA nephropathy in Blacks compared
with Whites. In both Blacks and Whites, IgA nephropathy has
IgA nephropathy in Blacks 949
Table 4. IgA nephropathy in the United States
a broad spectrum of clinical presentations that correlate with
the severity of the underlying renal parenchymal injury.
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